文献速递流行病学与生物统计真实世界研究与卫生经济

靶向疟疾消除干预的溢出效应扩展了疗效范围

Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects.
PubMed 文献 · Nat Med · 2024-07-04

该研究重新分析纳米比亚一项整群随机试验,评估在确诊病例500米内实施的反应性焦点干预(化学预防和/或室内滞留喷洒)的直接效应及3公里内非干预者的溢出效应。直接效应证据弱或无,但联合干预对1公里内非干预者降低疟疾发病率43%,对3公里内非干预者降低感染患病率79%、血清阳性率34%,并使成本效果提高42%。

要点

  • 联合化学预防和室内滞留喷洒对1公里内非干预者降低疟疾发病率43%。
  • 联合干预对3公里内非干预者降低感染患病率79%,降低血清阳性率34%。
  • 考虑溢出效应后,联合干预的成本效果提高42%。

核心结论

  • 靶向热点地区的联合化学预防和病媒控制干预可间接惠及最远3公里外的非干预者。

研究设计与样本

  • 重新分析纳米比亚一项整群随机试验,干预为在确诊病例500米内实施的反应性焦点化学预防(蒿甲醚-苯芴醇)和/或室内滞留喷洒(甲基嘧啶磷)。

主要发现

  • 直接效应证据无或弱,但干预接受者样本量小限制了统计效能。
  • 联合化学预防和室内滞留喷洒的溢出效应证据最强。
  • 1公里内非干预者中,联合干预使疟疾发病率降低43%(95%CI 20-59%)。
  • 3公里内非干预者中,联合干预使感染患病率降低79%(95%CI 6-95%),血清阳性率降低34%(95%CI 20-45%)。
  • 考虑溢出效应后,联合干预的成本效果提高42%。

关键数值与推荐

  • 1公里内非干预者疟疾发病率降低43%(95%CI 20-59%)。
  • 3公里内非干预者感染患病率降低79%(95%CI 6-95%),血清阳性率降低34%(95%CI 20-45%)。
  • 成本效果提高42%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 干预接受者样本量小,限制了统计效能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Malaria-elimination interventions aim to extinguish hotspots and prevent transmission to nearby areas. Here, we re-analyzed a cluster-randomized trial of reactive, focal interventions (chemoprevention using artemether-lumefantrine and/or indoor residual spraying with pirimiphos-methyl) delivered within 500 m of confirmed malaria index cases in Namibia to measure direct effects (among intervention recipients within 500 m) and spillover effects (among non-intervention recipients within 3 km) on incidence, prevalence and seroprevalence. There was no or weak evidence of direct effects, but the sample size of intervention recipients was small, limiting statistical power. There was the strongest evidence of spillover effects of combined chemoprevention and indoor residual spraying. Among non-recipients within 1 km of index cases, the combined intervention reduced malaria incidence by 43% (95% confidence interval, 20-59%). In analyses among non-recipients within 3 km of interventions, the combined intervention reduced infection prevalence by 79% (6-95%) and seroprevalence, which captures recent infections and has higher statistical power, by 34% (20-45%). Accounting for spillover effects increased the cost-effectiveness of the combined intervention by 42%. Targeting hotspots with combined chemoprevention and vector-control interventions can indirectly benefit non-recipients up to 3 km away.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Benjamin-Chung J, Li H, Nguyen A, et al. Extension of efficacy range for targeted malaria-elimination interventions due to spillover effects. Nat Med. 2024. PMID: 38965434. doi:10.1038/s41591-024-03134-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。